Member Info for LTbeliever

Https://www.jjstech.com/modern-water-microtox--microtox--lx-analyzer.html?srsltid=AfmBOoqMM4QivYort1QuTkKfUzFGWoK2jl2BzNmWLouuClXpA_KkqxEE

this looks like a 2023 link, so it was $34.000 2 years ago (Retail price), about £26k; might be more expensive now, given the upgrades?

Also, I found mentions of "2900 LXs in operation", again from 2023 or before, implying a solid base of reagents' demand.

DYOR, GLA.

We had 34 LX's invoiced in H1, and production was 3 per week B4 the fund raise (whose purpose was to increase LX production + increase GMargins simultaneously); there are 26 weeks to Y/E, if sales are 4 per week, this equates to 100 LXs in H2 i.e. a gross profit of £1million?? Even if half of that, the Co will be making 70-80% margins on re-agent sales.

These are the global distributors, incl. MW China; the MLN $ question is how much do they sell each MTox LX and what is the margin? I had found on the internet in the past a Retail price of $30.000, so if MW sells to the Distributors for - say - £20k, and has a 50% GPr margin, that means a gross profit of £10k per LX machine? The update next week will not have any breakdown, probably only the cash as at 30 June, and the Revenues for H1.

https://www.modernwater.com/partners/

That's 9% of the funds raised! :) must be expecting good things this H2 2025.

Https://www.modernwater.com/2025/07/16/business-development-manager/

BTW, I bought 760k y'day at 0.717; still shows as a SELL.

Who is HL?

0.70 Bid, 0.717 Offer; the algorithm shows as SELL anything below the mid-point of the range; thus, if range is 0.70-0.75 any BUYs below 0.725 are shown as SELLS.

As to why we are close to profitability.

https://www.turnerpope.com/wp-content/uploads/2025/06/Metirplc_30-5-2025_FINAL_BG.pdf

Hopefully, the interim report in a few days will increase MET's market visibility. GLA!

RNS will be released, it's an obligation, not up to their word; need to advise the price paid for their new shares too.

Added another 760k...let's see in 2 weeks :)

1mln share nibbles? :)

Mine is the 240k one, showing as a sell; so basically, only buys today.

U r welcome Nesnoor; I am sure - on this mkt cap of 2mln - you will definitely make money; I plan to buy more soon, when cash-situation allows me.

2.32-2.50, spread tightening. GLA!

Looks like a material deal and/or the Cloan extension will be announced soon?

BTW, it had said that they were producing 3 LXs per week and needed the fundraising to increase this number to satisfy demand but also increase GMargin; this means - say 4-5 per week - in H2 i.e. 100 LXs to be sold (25 weeks?) - if @£20k, that's a Sales figure of £2mln and a minimum GP of 1mln?

Finally, some numbers for fun (!); we will get a Trading Update by month end, for H1 2025; we already know that Mtox LX sales were around 34; if Co sells them for £20k, with a GM of 50%, this means Microtox LX equip. sales of £600k and GProfit of £300k (just a guess); we have reagent sales - maybe £200-300k (we had 113k in 2024, for just a few weeks and a lot less equipment installed), plus the Qatar half of appx £230k (other half in H2 2025); so, I reckon that for H1 we will get a headline Sales figure of £1mln (mostly depends on LX sale price), and a GProfit of 500k? Co had said last year that it needed sales of 80k per month (excl. Qatar) to cover its oper exps, meaning monthly O/Hs were about 40k?

Thus, for H1 2025, the Co will be close to B/E and that's why it expects EBITDA positive result in H2 - IMO. We will know in less than 3 weeks. GLA

Nesnoor, what's important is that the reagents, which are needed continually by the equipment to run, are high margin-low capital; what eats the WCap is equipment sales/installation but there will be a point where reagent sales for already-installed equipment will cover the fixed overheads; that'll be the inflexion point and it'd happen in late 2025, or 2026; and now MET is fully funded until that time. So, very little downside risk IMO (unlike KP2 which needs 2bln in capital and any divergence will still eat a lot of cash).

£20mln I meant; and MET took over most of this business (knowhow, IP, reagents, network, clients) for £100k (plus the £1mln of debt owed by DVRG, written off); so you can see the dynamics - not potential, because sales are already happening at an increasing rate (which enabled the fund raising to be successful).

Hi Nesnoor, 2 more important points; Mkt cap is now appx 2mln (share issue not yet reflected anywhere!), out of which 1mln is cash.

Secondly, MET took over in Jan 2024 the business of Modern Water, which was around for over 20 years (mostly loss making), with a big network of clients/distributors (USA, EU, Asia etc), and itself was taken over in 2020 (thereabouts) by Deepverge for 20mln (!!!) in shares; Deepverge went bust due to bad cash mgt (can't say fraud!), taking with it 1mln of MET's cash (in a bad debt) - leading to the changes of late 2023-Jan 2024. MET (ex MSYS) was sharing the same CEO with Deepverge for a year or so (which led to the demise of both).

MET now has its finger in many pies, only headwind is need to preserve cash. But we are getting near to the inflexion point IMO.

Socials usually reflect public info (cannot post unpublished info); could be someone building a position gradually (which explains why the Bid has not moved up IMO), or the MM expects some material news soon and is also stock-building (leaving spread wide to discourage sellers prior to news' release); can't say, usually such big spreads are pre-empting something, that insiders only know. Whatever it is, rising SP (even lop-sided) is welcome.